中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway

文献类型:期刊论文

作者Fang, Jun1,2; Wang, Yuezhen1,2; Wang, Zhun1,2; Xie, Tieming2,3; Yan, Fengqin1,2,4; Wang, Lei1,2,3; Hua, Jianfeng5; Wang, Fangzheng1,2,4; Fu, Zhenfu1,2,4; Ye, Zhimin1,2,4
刊名TRANSLATIONAL CANCER RESEARCH
出版日期2020-07-01
卷号9
关键词Nanomicelle miR-34a esophageal carcinoma (EC) p53 SIRT1 drug resistance
ISSN号2218-676X
DOI10.21037/tcr-19-975
通讯作者Fu, Zhenfu(fuzf1000@163.com) ; Ye, Zhimin(yezm@zjcc.org.cn)
英文摘要Background: Esophageal carcinoma (EC) is one of the most deadly malignant tumors in the world. Surgery, combined with chemotherapy or radiotherapy, is the traditional strategy for the treatment of EC. Cisplatin (CDDP) is a common chemotherapy drug widely used to treat EC due to its powerful anti-tumor effect. However, CDDP is subject to intrinsic or acquired resistance in EC cells, which badly hinders the efficacy of chemotherapy. The resistance phenomenon is mostly caused by the p53 mutant in the EC and the low efficiency of the drug delivery system. Methods: In this study, a specially designed nanomicelle was used to promote the anti-tumor effect of chemotherapy drugs against the CDDP-resistant EC cells. The nanomicelle consisted of miR-34a, doxorubicin (DOX), polyethylene glycol (PEG), and other excipients in an appropriate ratio. Results: The results showed that the nanomicelle could exert significant cell proliferation inhibition and apoptosis-inducing effects in the CDDP-resistant EC cells. The endogenous expression of miR-34a in the CDDP-resistant EC cells was promoted by the incubation with the nanomicelle. After incubation with the nanomicelle, the expression of protein SIRT1 was inhibited, and the expression of caspase3 was promoted significantly in the CDDP-resistant EC cells. Conclusions: Our results indicate that the specially designed nanomicelle can exert promising anti-tumor effects by introducing miR-34a to inhibit SIRT1 signaling pathway and enhance the efficiency of the drug delivery system.
WOS关键词CANCER-CELLS ; P53 ; CHEMORADIOTHERAPY ; ADENOCARCINOMAS ; SURVIVAL ; DELIVERY ; PROTEIN
资助项目National Natural Science Foundation of China[81502647] ; National Natural Science Foundation of China[81502646] ; Zhejiang Provincial Natural Science Foundation of China[LY17H160039] ; Zhejiang Provincial Natural Science Foundation of China[LY18H160031] ; Zhejiang Provincial Natural Science Foundation of China[LY19H160004] ; Zhejiang Medical and Health Science and Technology Project[2016KYA051] ; Zhejiang Medical and Health Science and Technology Project[2016146960] ; Zhejiang Medical and Health Science and Technology Project[2018RC083] ; Zhejiang Medical and Health Science and Technology Project[2018260661] ; Zhejiang Medical and Health Science and Technology Project[2019328882]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000553238500011
出版者AME PUBL CO
资助机构National Natural Science Foundation of China ; Zhejiang Provincial Natural Science Foundation of China ; Zhejiang Medical and Health Science and Technology Project
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/102917]  
专题中国科学院合肥物质科学研究院
通讯作者Fu, Zhenfu; Ye, Zhimin
作者单位1.Univ Chinese Acad Sci, Dept Radiat Oncol, Canc Hosp, Zhejiang Canc Hosp, Banshan East Rd, Hangzhou, Peoples R China
2.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China
3.Univ Chinese Acad Sci, Dept Radiol, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
4.Key Lab Head & Neck Canc Translat Res Zhejiang Pr, Banshan East Rd, Hangzhou, Peoples R China
5.Quzhou Kecheng Hosp, Dept Radiat Oncol, Quzhou, Peoples R China
推荐引用方式
GB/T 7714
Fang, Jun,Wang, Yuezhen,Wang, Zhun,et al. A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway[J]. TRANSLATIONAL CANCER RESEARCH,2020,9.
APA Fang, Jun.,Wang, Yuezhen.,Wang, Zhun.,Xie, Tieming.,Yan, Fengqin.,...&Ye, Zhimin.(2020).A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway.TRANSLATIONAL CANCER RESEARCH,9.
MLA Fang, Jun,et al."A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway".TRANSLATIONAL CANCER RESEARCH 9(2020).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。